Recombinant SARS-CoV-2 Spike glycoprotein (RBD (Arg306-Phe527) [hFc tag], HEK293 (CAT#: GP05-055J)

Product Overview	Recombinant 2019-nCoV/SARS-CoV-2 Spike glycoprotein (YP_009724390.1) RBD (Arg306-Phe527) was produced in HEK293 cells with a hFc tag at the C-terminus. Measured by its binding ability in a functional ELISA with recombinant human ACE-2.
Biological Activity	Measured by its binding ability in a functional ELISA with recombinant human ACE-2.
Source	HEK293 cells
Species	2019-nCoV/SARS-CoV-2
Fragment	RBD (Arg306-Phe527)
Tag	hFc tag at the C-terminus
Predicted N Terminal	Arg 306
Predicted MW	52 kDa
Purity	>95%, determined by SDS-PAGE.
Endotoxin Level	<0.1 EU/μg, determined by LAL method.
Conjugation	Unconjugated

Target	S
Full Name	Spike glycoprotein
Gene ID	43740568
Uniprot ID	P59594.1
Accession Number	YP_009724390.1
Background	The S protein mediates attachment of the virus to cell-surface receptors and fusion between virus and cell membranes.
Alternate Names	Spike glycoprotein